Pharmacology · Anti-Mycobacterial Drugs (Anti-TB, Anti-Leprosy)

A 45-year-old man on intensive phase anti-TB therapy complains of difficulty distinguishing traffic light colours after 3 months of treatment. Visual acuity testing shows bilateral reduction and loss of red-green colour discrimination. The most likely causative drug and its dose-dependent toxic target are:

  • A Isoniazid, optic nerve demyelination
  • B Streptomycin, vestibulocochlear nerve damage
  • C Ethambutol, retrobulbar neuritis affecting the papillomacular bundle
  • D Rifampicin, cortical visual processing defect
Correct answer: C. Ethambutol, retrobulbar neuritis affecting the papillomacular bundle

Explanation

Ethambutol causes a dose-dependent optic neuropathy that classically presents with impaired red-green colour vision before loss of visual acuity, reflecting damage to the papillomacular bundle. The risk rises above 15 mg/kg/day and in renal impairment. Isoniazid can rarely cause optic neuritis, but colour vision loss as the earliest sign points to ethambutol. Baseline and monthly visual assessment is advised.

Reference: Katzung's Basic and Clinical Pharmacology, 16th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 43,000+ MCQs.

Start free → Log in

More Anti-Mycobacterial Drugs (Anti-TB, Anti-Leprosy) MCQs

See all Anti-Mycobacterial Drugs (Anti-TB, Anti-Leprosy) MCQs →